NEOMED and UH host a Neurodegenerative Disease and Aging Symposium
NEOMED and University Hospitals (UH) hosted a successful Neurodegenerative Disease and Aging Symposium, bringing together leading researchers, clinicians and trainees to advance the understanding and treatment of neurological conditions. This collaborative event served as a vital platform to foster interdisciplinary dialogue, showcase cutting-edge research, and identify new avenues for team science, training and clinical impact.
Sheila Fleming, Ph.D., director of the Neurodegenerative Disease and Aging Research Focus Area, underscored the importance of in-person collaboration, stating, “Strong collaborations start with common goals and commitment, the best way to begin was to meet in person and listen to each other. With this symposium, I feel like we are off to a great start.”
The symposium featured insightful thematic presentations by experts in the field. These sessions delved into various aspects of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and traumatic brain injuries, exploring the latest discoveries in underlying mechanisms, potential biomarkers and therapeutic strategies. Attendees also had the opportunity to engage with a diverse array of groundbreaking work through engaging poster presentations, highlighting the breadth and depth of research being conducted at both UH and NEOMED.
Beyond the formal presentations, the symposium strongly emphasized open discussion and networking opportunities. These informal interactions proved invaluable, facilitating the exchange of ideas, forging new connections and laying the groundwork for future collaborations. The shared commitment to tackling these complex diseases was palpable, and the symposium successfully ignited conversations that will undoubtedly lead to innovative research projects and a more unified approach to patient care.
The UH-NEOMED partnership is dedicated to driving new opportunities for research collaboration, integrating initiatives from basic to clinical and translational scientific studies. “This partnership brings together incredible clinical expertise and strong basic science research with both focused on advancing scientific discoveries and improving the quality of life for people as they age,” Dr. Fleming said, highlighting the synergy of the partnership.
Gallery
